Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geer

Showing results (941-950 of 1,197) with videos related to

Pageof 120
Sort By:
Frontiers in Immunology|July 1, 2024
Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphomaDavid G Frame, Marcus Geer, Salena Kasha, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Terminally Differentiated Influenza-Specific Effector Memory B Cells Circulate after Live Attenuated Influenza VaccinationAnoma Nellore, Christopher Fucile, Christopher Scharer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Environmental Health Perspectives|June 21, 2017
The Florence Statement on Triclosan and TriclocarbanRolf U Halden, Avery E Lindeman, Allison E Aiello, et al.
Blood|June 20, 1998
Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemiaH Wandt, M Frank, G Ehninger, et al.
Journal of the Air & Waste Management Association (1995)|March 22, 2023
Characterization of PFAS air emissions from thermal application of fluoropolymer dispersions on fabricsLindsay C Wickersham, James M Mattila, Jonathan D Krug, et al.
Radiation Oncology (London, England)|August 5, 2025
A prospective outcomes and cost-effective analysis of surgery compared to stereotactic body radiation therapy for stage I non-small cell lung cancerAndrew Kennedy, Shanna A Arnold Egloff, Casey Martin, et al.
British Journal of Cancer|September 26, 2013
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryJ Posthumadeboer, S R Piersma, T V Pham, et al.
Breast Cancer Research and Treatment|January 4, 2021
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysisAnnaLynn M Williams, Carly Paterson Khan, Charles E Heckler, et al.
Pageof 120

Showing results (941-950 of 1,197) with videos related to

Sort By:
Pageof 120
Frontiers in Immunology|July 1, 2024
Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphomaDavid G Frame, Marcus Geer, Salena Kasha, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Terminally Differentiated Influenza-Specific Effector Memory B Cells Circulate after Live Attenuated Influenza VaccinationAnoma Nellore, Christopher Fucile, Christopher Scharer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Environmental Health Perspectives|June 21, 2017
The Florence Statement on Triclosan and TriclocarbanRolf U Halden, Avery E Lindeman, Allison E Aiello, et al.
Blood|June 20, 1998
Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemiaH Wandt, M Frank, G Ehninger, et al.
Journal of the Air & Waste Management Association (1995)|March 22, 2023
Characterization of PFAS air emissions from thermal application of fluoropolymer dispersions on fabricsLindsay C Wickersham, James M Mattila, Jonathan D Krug, et al.
Radiation Oncology (London, England)|August 5, 2025
A prospective outcomes and cost-effective analysis of surgery compared to stereotactic body radiation therapy for stage I non-small cell lung cancerAndrew Kennedy, Shanna A Arnold Egloff, Casey Martin, et al.
British Journal of Cancer|September 26, 2013
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryJ Posthumadeboer, S R Piersma, T V Pham, et al.
Breast Cancer Research and Treatment|January 4, 2021
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysisAnnaLynn M Williams, Carly Paterson Khan, Charles E Heckler, et al.
Pageof 120